{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:40:30Z","timestamp":1788615630822,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019433","name":"Shibuya Science Culture and Sports Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K06957"],"award-info":[{"award-number":["22K06957"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.prp.2025.155999","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:23:33Z","timestamp":1746757413000},"page":"155999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic re-classification of combined hepatocellular-cholangiocarcinoma and small duct type intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-760X","authenticated-orcid":false,"given":"Motoko","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuni","family":"Nakanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155999_bib1","series-title":"WHO Classification of Tumours. Digestive System Tumours, 5th edition ed","article-title":"Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma","author":"Sempoux","year":"2019"},{"key":"10.1016\/j.prp.2025.155999_bib2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","article-title":"Combined hepatocellular-cholangiocarcinoma: an update","volume":"74","author":"Beaufrere","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2025.155999_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2025.155999_bib4","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1038\/s41467-023-43749-3","article-title":"Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma","volume":"14","author":"Calderaro","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.prp.2025.155999_bib5","article-title":"Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning","author":"Beaufrere","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.prp.2025.155999_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/his.14622","article-title":"Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?","volume":"80","author":"Sasaki","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155999_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00428-024-03792-x","article-title":"Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study","volume":"484","author":"Sasaki","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.155999_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.155999_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100466","volume":"37","author":"Choi","year":"2024","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"wbe Cancer Genome Atlas Research Network, Electronic address, N. Cancer Genome Atlas Research","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.155999_bib11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2025.155999_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2025.155999_bib13","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1038\/s41598-018-25669-1","article-title":"Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma","volume":"8","author":"Simbolo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.155999_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2025.155999_bib15","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.155999_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2025.155999_bib17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2025.155999_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2025.155999_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2025.155999_bib20","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155999_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2025.155999_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1078-0432.CCR-21-1219","article-title":"Immune profiling of combined hepatocellular- cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy","volume":"28","author":"Nguyen","year":"2022","journal-title":"Clin. Cancer Res"},{"issue":"5","key":"10.1016\/j.prp.2025.155999_bib23","doi-asserted-by":"crossref","DOI":"10.1200\/PO.20.00397","article-title":"Genomic profiling of combined hepatocellular cholangiocarcinoma reveals genomics similar to either hepatocellular carcinoma or cholangiocarcinoma","author":"Murugesan","year":"2021","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.prp.2025.155999_bib24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","article-title":"Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes","volume":"35","author":"Xue","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2025.155999_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/his.13084","article-title":"Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance","volume":"70","author":"Sasaki","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155999_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAS.0000000000001201","article-title":"Cholangiolocellular carcinoma with \"Ductal Plate Malformation\" pattern may be characterized by ARID1A genetic alterations","volume":"43","author":"Sasaki","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/his.14932","article-title":"Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components","volume":"83","author":"Sasaki","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155999_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"Kobel","year":"2016","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.prp.2025.155999_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2025.155999_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13234","article-title":"PBRM1 loss is a late event during the development of cholangiocarcinoma","volume":"71","author":"Luchini","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155999_bib33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.2017.23","article-title":"SF3B1 and BAP1 mutations in blue nevus-like melanoma","volume":"30","author":"Griewank","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/hepr.13875","article-title":"Prognostic significance for recurrence of fibroblast growth factor receptor 2 in intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection","volume":"53","author":"Toshida","year":"2023","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.prp.2025.155999_bib36","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2025.155999_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41467-018-03276-y","article-title":"Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.155999_bib38","article-title":"Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity","author":"Liu","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prp.2025.155999_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-14-3296","article-title":"Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma","volume":"22","author":"Moeini","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2025.155999_bib40","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/liv.12563","article-title":"Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma","volume":"35","author":"Sasaki","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.prp.2025.155999_bib41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/carcin\/bgs208","article-title":"Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFbeta signaling pathways","volume":"33","author":"Coulouarn","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2025.155999_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-9896(199806)185:2<191::AID-PATH81>3.0.CO;2-P","article-title":"Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis","volume":"185","author":"Sasaki","year":"1998","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.155999_bib43","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1478-3231.2012.02783.x","article-title":"Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers","volume":"32","author":"Xu","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.prp.2025.155999_bib44","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2025.155999_bib45","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2022.11.030","article-title":"Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma","volume":"78","author":"Kendre","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2025.155999_bib46","article-title":"Prognostic impact of the cholangiolar component in combined hepatocellular-cholangiocarcinoma: insights from a western single-center study","author":"Nolasco","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.prp.2025.155999_bib47","article-title":"Is it necessary to distinguish between combined hepatocellular carcinoma-cholangiocarcinoma with less than 10% of cholangiocarcinoma components versus hepatocellular carcinoma?","author":"Zhou","year":"2024","journal-title":"Hepatol. Int."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:29:02Z","timestamp":1778747342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S0344033825001918"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155999","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic re-classification of combined hepatocellular-cholangiocarcinoma and small duct type intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155999"}}